Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
2020 · Stem Cell Research & Therapy · 28 citations
https://doi.org/10.1186/s13287-020-01973-4
Z
Zhengchun Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
231
Citations
9
h-index
9
i10-index
Zhengchun Liu is an academic researcher from Weifang Medical University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Ferroptosis and cancer prognosis & Epigenetics and DNA Methylation. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0000-0002-9779-3531Papers by this author
worksPrognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma
2016 · Radiation Oncology · 10 citations
https://doi.org/10.1186/s13014-016-0696-5
Additional file 1 of Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13159190
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat